Patents by Inventor Subash C. Jonnalagadda

Subash C. Jonnalagadda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Functionalized aminobenzoboroxoles
    Patent number: 10633399
    Abstract: Disclosed are functionalized aminobenzoboroxoles compounds, method for preparing these compounds, and methods for treating cancers.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: April 28, 2020
    Assignee: Channel Therapeutics, Inc.
    Inventors: Kandalam V. Ramanujachary, Subash C. Jonnalagadda
  • Salinomycin derivatives and therapeutic uses thereof
    Patent number: 10364253
    Abstract: The invention relates to salinomycin derivatives such as compounds having the structure of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a therapeutically effective amount of compounds of formula (I), and the use of compounds of formula (I) for treating or inhibiting progression of cancer. The cancer is selected from the group consisting of breast cancer, pancreatic cancer, and prostate cancer.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: July 30, 2019
    Assignee: Channel Therapeutics, Inc.
    Inventors: Sireesh Appajosyula, Kandalam V. Ramanujachary, Subash C. Jonnalagadda
  • FUNCTIONALIZED AMINOBENZOBOROXOLES
    Publication number: 20180230169
    Abstract: Disclosed are functionalized aminobenzoboroxoles compounds, method for preparing these compounds, and methods for treating cancers.
    Type: Application
    Filed: August 15, 2016
    Publication date: August 16, 2018
    Inventors: Kandalam V. Ramanujachary, Subash C. Jonnalagadda
  • SALINOMYCIN DERIVATIVES AND THERAPEUTIC USES THEREOF
    Publication number: 20180230163
    Abstract: The invention relates to salinomycin derivatives such as compounds having the structure of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a therapeutically effective amount of compounds of formula (I), and the use of compounds of formula (I) for treating or inhibiting progression of cancer. The cancer is selected from the group consisting of breast cancer, pancreatic cancer, and prostate cancer.
    Type: Application
    Filed: August 15, 2016
    Publication date: August 16, 2018
    Inventors: Sireesh Appajosyula, Kandalam V. Ramanujachary, Subash C. Jonnalagadda